767
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Prostatic protective nature of the flavonoid-rich fraction from Cyclosorus acuminatus on carrageenan-induced non-bacterial prostatitis in rat

, , &
Pages 491-497 | Received 22 Jun 2013, Accepted 16 Sep 2013, Published online: 21 Nov 2013

References

  • Agbabiaka TB, Pittler MH, Wider B, Ernst E. (2009). Serenoa repens (Saw Palmetto): A systematic review of adverse events. Drug Saf 32:637–47
  • Chan MM, Mattiacci JA, Hwang HS, et al. (2000). Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Biochem Pharmacol 60:1539–48
  • Chen JL, Lei YF, Liu YJ, et al. (2011). Extract of Cyclosorus acuminatus attenuates diabetic nephropathy in mice via modifying peroxisome proliferaors activated receptor signaling pathway. Food Chem 128:659–66
  • Chen RZ, Cui L, Guo YJ, et al. (2011). In vivo study of four preparative extracts of Clematis terniflora DC. for antiociceptive activity and anti-inflammatory activity in rat model of carrageenan-induced chronic non-bacterial prostatitis. J Ethnopharmacol 134:1018–23
  • Chow YL, Lee KH, Vidyadaran S, et al. (2012). Cardamonin from Alpinia rafflesiana inhibits inflammatory responses in IFN-γ/LPS-stimulated BV2 microglia via NF-κB signalling pathway. Int Immunopharmacol 12:657–65
  • Dayer JM, Beutler B, Cerami A. (1985). Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 162:2163–8
  • Fang W, Ruan J, Wang Z, et al. (2006). Acetylated flavanone glycosides from the rhizomes of Cyclosorus acuminatus. J Nat Prod 69:1641–4
  • Han M, Wen JK, Zheng B, Zhang DQ. (2004). Acetylbritannilatone suppresses NO and PGE2 synthesis in RAW 264.7 macrophages through the inhibition of iNOS and COX-2 gene expression. Life Sci 75:675–84
  • Hu XM, Zhang WK, Zhu QS, et al. (1998). Editorial Board of China Herb of State Administration of Traditional Chinese Medicine. China herbal. Shanghai, China: Shanghai Scientific and Technical Publishers, 0551–4
  • Jeong JC, Yoon CH, Lee WH, et al. (2005). Effects of Bambusae concretio Salicea (Chunchukhwang) on amyloid beta-induced cell toxicity and antioxidative enzymes in cultured rat neuronal astrocytes. J Ethnopharmacol 98:259–66
  • Ji JD, Cheon H, Jun JB, et al. (2001). Effects of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) on the expression of inflammatory cytokines and apoptosis induction in rheumatoid synovial fibroblasts and monocytes. J Autoimmun 17:215–21
  • Jiang M, Strand DW, Franco OE, et al. (2011). PPARγ: A molecular link between systemic metabolic disease and benign prostate hyperplasia. Differentiation 82:220–36
  • Joseph MA, Harlow SD, Wei JT, et al. (2003). Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. Am J Epidemiol 157:906–14
  • Kersten S, Desvergne B, Wahli W. (2000). Roles of PPARs in health and disease. Nature 405:421–4
  • Kim EK, Kwon KB, Koo BS, et al. (2007). Activation of peroxisome proliferator-activated receptor-γ protects pancreatic β-cells from cytokine-induced cytotoxicity via NFκB pathway. Int J Biochem Cell Biol 39:1260–75
  • Lee HS, Kwon SH, Ham JE, et al. (2012). Zaprinast activates MAPKs, NFκB, and Akt and induces the expressions of inflammatory genes in microglia. Int Immunopharmacol 13:232–41
  • Lei Y, Fu W, Chen J, et al. (2011). Neuroprotective effects of abacopterin E from Abacopteris penanagiana against oxidative stress stress-induced neurotoxicity. J Ethnopharmacol 134:275–80
  • Liang M, Yang H, Fu J. (2009). Nimesulide inhibits IFN-γ programmed death-1-ligand 1 surface expression in breast cancer cells by COX-2 and PGE2 independent mechanisms. Cancer Lett 276:47–52
  • Lin DW, Nelson PS. (2003). The role of cyclooxygenase-2 inhibition for the prevention and treatment of prostate carcinoma. Clin Prostate Cancer 2:119–26
  • Lu B, Cai H, Huang W, et al. (2011). Protective effect of bamboo shoot oil on experimental nonbacterial prostatitis in rats. Food Chem 124:1017–23
  • Luzzi GA. (2002). Chronic prostatitis and chronic pelvic pain in men: Aetiology, diagnosis and management. J Eur Acad Dermatol Venereol 16:253–6
  • Mann JR, Backlund MG, DuBois RN. (2005). Mechanisms of disease: Inflammatory mediators and cancer prevention. Nat Clin Pract Oncol 2:202–10
  • Matsuyama M, Yoshimura R. (2008). Peroxisome proliferators-activated receptor-γ is a potent target for prevention and treatment in human prostate and testicular cancer. PPAR Res 2008:249849 (1--12)
  • Milsom AB, Patel NS, Mazzon E, et al. (2010). Role for endothelial nitric oxide synthase in nitrite-induced protection against renal ischemia-reperfusion injury in mice. Nitric Oxide 22:141–8
  • Nadler RB, Koch AE, Calhoun EA, et al. (2000). IL-1 beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol 164:214–18
  • Nishimura K, Takayama H, Nakayama M, et al. (2006). Molecular-targeted therapy for hormone-refractory prostate cancer. Hinyokika Kiyo 52:487–90
  • Park JY, Cho HY, Kim JK, et al. (2005). Chlorella dichloromethane extract ameliorates NO production and iNOS expression through the down-regulation of NFκB activity mediated by suppressed oxidative stress in RAW 264.7 macrophages. Clin Chim Acta 351:185–96
  • Pei Z, Li H, Guo Y, et al. (2010). Sodium selenite inhibits the expression of VEGF, TGFβ1 and IL-6 induced by LPS in human PC3 via TLR4-NFκB signaling blockage. Int Immunopharmacol 10:50–6
  • Ricote M, Li AC, Willson TM, et al. (1998). The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391:79–82
  • Sánchez-Hidalgo M, Martín AR, et al. (2005). Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats. Biochem Pharmacol 69:1733–44
  • Sareila O, Korhonen R, Kärpänniemi O, et al. (2008). Janus kinase 3 inhibitor WHI-P154 in macrophages activated by bacterial endotoxin: Differential effects on the expression of iNOS, COX-2 and THF-α. Int Immunopharmacol 8:100–8
  • Segawa Y, Yoshimura R, Hase T, et al. (2002). Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer. Prostate 51:108–16
  • Suh LK, Lowe FC. (2011). Alternative therapies for the treatment of chronic prostatitis. Curr Urol Rep 12:284–7
  • Suzuki Y, Deitch EA, Mishima S, et al. (2000). Inducible nitric oxide synthase gene knockout mice have increased resistance to gut injury and bacterial translocation after an intestinal ischemia reperfusion injury. Crit Care Med 28:3692–6
  • Yoshimura R, Matsuyama M, Segawa Y, et al. (2004). Study of peroxisome proliferator-activated receptor (PPAR)-gamma in renal ischemia-reperfusion injury. Transplant Proc 36:1946–8
  • Zhang H, Matsuda H, Yamashita C, et al. (2009). Hydrangeic acid from the processed leaves of Hydrangea macrophylla var. thunbergii as a new type of anti-diabetic compound. Eur J Pharmacol 606:255–61
  • Zheng M, Ye S, Zhai Z, et al. (2009). Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal moncyte chemoattractant protein-1 expression. J Diabetes Complications 23:124–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.